Methods Patients with a breast cancer diagnosis were prescribed GLP-1 RAs from January 1, 2015, to December 31, 2023, at Memorial Sloan Kettering Cancer Center in New York, New York, with follow-up weight data (before and during treatment with a GLP-1 RA) included in this retrospective cohort
Format options Pre-blended vials (most common: 12.5 mg reta + 2.5 mg cag) or two separate vials
This confounding makes it difficult to determine whether any observed risk is due to the medication or underlying patient characteristics
The Glow Therapy line especially stands out for formulas that focus on visible radiance, smoother-looking texture, and well-balanced hydration
The caveat is quality: Many commercial whey products contain fillers, prebiotics, and sweeteners that irritate the gut, which can cause people to mistakenly conclude they dont tolerate whey